Dr Kas Laboratries Private Limited - Due diligence report

A 360° intelligence report on Dr Kas Laboratries Private Limited: trust score, financial health, credit view, compliance, directors, growth …

2016-12-01 Shamli, Uttar Pradesh Active Unlisted Active Compliant
Share
Connect MCP
DK Dr Kas Laboratries Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Dr Kas Laboratries Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Dr Kas Laboratries Private Limited is assessed as Low Risk with a Trust Score of 75/100. Dr Kas Laboratries Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Chemicals sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 02 Aug 2026 from the latest processed filings. Dr Kas Laboratries Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
45/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
MOHD AFSAR NADEEM 01234567 Director 01/04/2018 6 yrs Approved
MOHD FAIZAN 01234567 Director 01/04/2018 6 yrs Approved
SHAN ALAM 01234567 Director 01/04/2018 6 yrs Approved
MOHD AHASAN 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • MOHD AFSAR NADEEM has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 90
Growth signals & trust indicators
Operating for 9 years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence90/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment68/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view54/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 7 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
01 Dec 2016
Incorporated
Registered with Roc Kanpur
Director appointed
MOHD AFSAR NADEEM (Director)
Director appointed
MOHD FAIZAN (Director)
Director appointed
SHAN ALAM (Director)
Director appointed
MOHD AHASAN (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2018 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Novacept Chemex Private Limited U24299MH2020PTC351934 Nashik, Maharashtra, India
Ashtakarma Healthcare (Opc) Private Limited U74999MH2016OPC281025 Thane, Maharashtra, India
Grapsum Healthcare Private Limited U24233MP2011PTC026051 Indore, Madhya Pradesh, India
Bionek Pharmaceuticals Private Limited U85300UP2020PTC135361 Varanasi, Uttar Pradesh, India
Shree Gautam Multi Chem Private Limited U24243GJ2006PTC048059 Ahmedabad, Gujarat, India
Smu Sales Private Limited U51101RJ2015PTC047027 Jaipur, Rajasthan, India
Vidhyanagar Pigments Pvt Ltd U27109GJ1991PTC015361 Anand, Gujarat, India
Athenz Envitech Private Limited U37200KA2012PTC064341 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Dr Kas Laboratries Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Dr Kas Laboratries Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Dr Kas Laboratries Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Dr Kas Laboratries Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Dr Kas Laboratries Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Dr Kas Laboratries Private Limited an active company?

Dr Kas Laboratries Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Dr Kas Laboratries Private Limited financially healthy?

Dr Kas Laboratries Private Limited has a Financial Health Score of 45/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Dr Kas Laboratries Private Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Dr Kas Laboratries Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Dr Kas Laboratries Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Dr Kas Laboratries Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Dr Kas Laboratries Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.